Multiple cerebral hemorrhagic foci from metastases during temozolomide treatment in a patient with corticotroph pituitary carcinoma.
Endocrinology and Diabetology Unit, Department of Biomedical Sciences for Health, University of Milan, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Donato, 20097 San Donato Milanese, Italy.
Marco
M
Mendola
Elena
E
Passeri
Bruno
B
Ambrosi
Sabrina
S
Corbetta
D049913:ACTH-Secreting Pituitary Adenoma / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D000236:Adenoma / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000556:secondary*; D002543:Cerebral Hemorrhage / Q000139:chemically induced*; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide